TGen News & Press Releases : TGen Drug Development (TD2) partners with Horizon Discovery to offer an integrated personalized medicine service
  • Posted Tuesday November 27, 2018
A typo in a records request resulted in TGen's Center for Rare Childhood Disorders finding a long-sought diagnosis for one of their first patient-families.

Search



Media Contact



Blog Archive